u/amara_halonen
Contributes reviews on supplier material. Based in Monterrey.
member · joined 14 May 2025
Comments — page 2 of 3
comment on nobody warned me about reflux and I would have liked the warning in c/coa · 66 points · 8 months ago
post the whole document, not the headline number
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
comment on [Vendor] QST order #8 — Spain, 33 days, no drama, receipts inside in c/tirzepatide · 73 points · 8 months ago
comment on [Question] SURPASS — what am I missing here in c/tirzepatide · 7 points · 8 months ago
the 15mg is the top of the pen, not the required dose
comment on week 56 check-in — 12kg down, injection-site soreness manageable, one thing confusing me in c/coa · 21 points · 9 months ago
purity and net content are two different numbers, same vial Disagree on that part.
Disagree on that part. 95.1% and 98.9% on the same vial is normal.
comment on does Zepbound actually matter or is it forum lore at this point in c/tirzepatide · 67 points · 9 months ago
dual agonism is SURPASS, do not generalise from semaglutide
comment on [Lab] 15th independent test on QSC, and the trend is the interesting part in c/coa · 9 points · 10 months ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
comment on does area percent actually matter or is it forum lore at this point in c/coa · 5 points · 10 months ago
Small correction: the trial was 8 weeks, not 35. Does not change your point but people will quote it.
comment on switched from 12.5mg to 10mg and the nausea got better, not worse in c/tirzepatide · 38 points · 10 months ago
the GIP side does different things than the GLP-1 side, that is the point
Yes, exactly this, and it is the bit that took me 67 weeks to accept.
comment on why does nobody talk about certificate of analysis in c/coa · 1 points · 11 months ago
axis labels included, always
comment on [Question] how do you actually verify area percent in c/coa · 156 points · 11 months ago
the related substances line is where the story is
comment on [Meta] the SURMOUNT rule is doing its job and people should stop complaining in c/tirzepatide · 1 points · 1 year ago
the nausea from tirz is different, not necessarily worse
comment on the CagriSema question that gets asked weekly, answered properly in c/cagrilintide · 17 points · 1 year ago
Strongly agree. REDEFINE is phase 10, not final.
comment on am I the only one who found GIP harder than the injections in c/tirzepatide · 1.4k points · 1 year ago
nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing
comment on reading 15mg threads from 2024 and half of it aged badly in c/tirzepatide · -28 points · 1 year ago
comment on Germany: SURMOUNT, and what it actually costs here in c/tirzepatide · 0 points · 1 year ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on stalled for 17 weeks at 7.5mg and I refuse to panic this time in c/coa · 1 points · 1 year ago
redact your own name, not the vendor's batch details
comment on related substances is the most under-discussed thing in c/scamalerts in c/coa · 6 points · 1 year ago
the method line is doing real work, not just window dressing
comment on anyone else notice SURMOUNT kicking in around week 30 in c/tirzepatide · 342 points · 1 year ago
Switched from sema at 0.25mg to tirz at 15mg. Different drugs, cannot compare the doses directly.
comment on small win: GIP stopped being a problem at week 41 in c/tirzepatide · 30 points · 1 year ago
do not crack the pen, we have been over this
comment on what changed for me between week 35 and week 78 in c/tirzepatide · 599 points · 1 year ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.